Dihydroergotamine (injection): Difference between revisions

Dihydroergotamine (injection)
Clinical data
ATC code	N02CA01 (WHO) ;
Pharmacokinetic data
Elimination half-life	9 hours
Identifiers
CAS Number	511-12-6;
PubChem CID	10531;
DrugBank	APRD00476;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C33H37N5O5
Molar mass	583.678 g/mol

VisualWikitext

Revision as of 22:10, 11 February 2014

Dihydroergotamine
MIGRANAL (dihydroergotamine mesylate) spray^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Dihydroergotamine
ClinicalTrials.gov
Dihydroergotamine
D.H.E. 45 (dihydroergotamine mesylate) injection, solution^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Dihydroergotamine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information about Dihydroergotamine, click here.

Synonyms / Brand Names:

Overview

Dihydroergotamine is an ergot alkaloid used to treat migraines.

FDA Package Insert

MIGRANAL (dihydroergotamine mesylate) spray Normal 0 false false false EN-US X-NONE X-NONE

D.H.E. 45 (dihydroergotamine mesylate) injection, solution Normal 0 false false false EN-US X-NONE X-NONE

Mechanism of Action

Dihydroergotamine is an ergot alkaloid used to treat migraines.^[1] ^[1] Normal 0 false false false EN-US X-NONE X-NONE

References

↑ ^1.0 ^1.1 "MIGRANAL (DIHYDROERGOTAMINE MESYLATE) SPRAY [VALEANT PHARMACEUTICALS INTERNATIONAL]".

Template:Antimigraine preparations

Template:WH Template:WS

[dailymed.nlm.nih.gov-1] 1.0 ^1.1 "MIGRANAL (DIHYDROERGOTAMINE MESYLATE) SPRAY [VALEANT PHARMACEUTICALS INTERNATIONAL]".

[1]

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{XXXXX}}
+{{Dihydroergotamine}}
 {{CMG}}; {{AE}} {{PB}}
-'''''For patient information about XXXXX, click [[XXXXX (patient information)|here]].'''''
+'''''For patient information about Dihydroergotamine, click [[Dihydroergotamine (patient information)|here]].'''''
 {{SB}}
@@ Line 33: / Line 33: @@
 |routes_of_administration=
 }}
 '''Dihydroergotamine''' is an [[ergot]] alkaloid used to treat [[migraine]]s.
 ==Category==
@@ Line 46: / Line 40: @@
 ==FDA Package Insert==
-'''  [[XXXXX indications and usage|Indications and Usage]]'''
+==MIGRANAL (dihydroergotamine mesylate) spray   Normal  0          false  false  false    EN-US  X-NONE  X-NONE                                                                                                                                                                                                                                                                                                                                                            ==
-'''| [[XXXXX dosage and administration|Dosage and Administration]]'''
-'''| [[XXXXX dosage forms and strengths|Dosage Forms and Strengths]]'''
-'''| [[XXXXX contraindications|Contraindications]]'''
-'''| [[XXXXX warnings and precautions|Warnings and Precautions]]'''
-'''| [[XXXXX adverse reactions|Adverse Reactions]]'''
-'''| [[XXXXX drug interactions|Drug Interactions]]'''
-'''| [[XXXXX use in specific populations|Use in Specific Populations]]'''
-'''| [[XXXXX overdosage|Overdosage]]'''
-'''| [[XXXXX description|Description]]'''
-'''| [[XXXXX clinical pharmacology|Clinical Pharmacology]]'''
-'''| [[XXXXX nonclinical toxicology|Nonclinical Toxicology]]'''
-'''| [[XXXXX clinical studies|Clinical Studies]]'''
-'''| [[XXXXX how supplied storage and handling|How Supplied/Storage and Handling]]'''
-'''| [[XXXXX patient counseling information|Patient Counseling Information]]'''
-'''| [[XXXXX labels and packages|Labels and Packages]]'''
-==Mechanism of Action==
+'''  [[MIGRANAL (dihydroergotamine mesylate) spray indications and usage|Indications and Usage]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray dosage and administration|Dosage and Administration]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray dosage forms and strengths|Dosage Forms and Strengths]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray contraindications|Contraindications]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray warnings and precautions|Warnings and Precautions]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray adverse reactions|Adverse Reactions]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray drug interactions|Drug Interactions]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray use in specific populations|Use in Specific Populations]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray overdosage|Overdosage]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray description|Description]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray clinical pharmacology|Clinical Pharmacology]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray nonclinical toxicology|Nonclinical Toxicology]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray clinical studies|Clinical Studies]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray how supplied storage and handling|How Supplied/Storage and Handling]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray patient counseling information|Patient Counseling Information]]'''
+'''| [[MIGRANAL (dihydroergotamine mesylate) spray labels and packages|Labels and Packages]]'''
+==D.H.E. 45 (dihydroergotamine mesylate) injection, solution   Normal  0          false  false  false    EN-US  X-NONE  X-NONE                                                                                                                                                                                                                                                                                                                                                            ==
+'''  [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution indications and usage|Indications and Usage]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution dosage and administration|Dosage and Administration]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution dosage forms and strengths|Dosage Forms and Strengths]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution contraindications|Contraindications]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution warnings and precautions|Warnings and Precautions]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution adverse reactions|Adverse Reactions]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution drug interactions|Drug Interactions]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution use in specific populations|Use in Specific Populations]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution overdosage|Overdosage]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution description|Description]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution clinical pharmacology|Clinical Pharmacology]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution nonclinical toxicology|Nonclinical Toxicology]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution clinical studies|Clinical Studies]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution how supplied storage and handling|How Supplied/Storage and Handling]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution patient counseling information|Patient Counseling Information]]'''
+'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution labels and packages|Labels and Packages]]'''
+==Mechanism of Action==
-'''Dihydroergotamine''' is an [[ergot]] alkaloid used to treat [[migraine]]s.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = MIGRANAL (DIHYDROERGOTAMINE MESYLATE) SPRAY [VALEANT PHARMACEUTICALS INTERNATIONAL] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a24befa8-b952-48ac-942a-379585250782 | publisher =  | date =  | accessdate = }}</ref>
+'''Dihydroergotamine''' is an [[ergot]] alkaloid used to treat [[migraine]]s.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = MIGRANAL (DIHYDROERGOTAMINE MESYLATE) SPRAY [VALEANT PHARMACEUTICALS INTERNATIONAL] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a24befa8-b952-48ac-942a-379585250782 | publisher =  | date =  | accessdate = }}</ref> <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = D.H.E. 45 (DIHYDROERGOTAMINE MESYLATE) INJECTION, SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe826e6a-75c8-43ed-9c36-f8263ec35aff | publisher =  | date =  | accessdate = }}</ref>   Normal  0          false  false  false    EN-US  X-NONE  X-NONE
 ==References==
@@ Line 80: / Line 92: @@
 [[pl:Dihydroergotamina]]
 {{WH}}
 {{WS}}

Clinical data

ATC code	N02CA01 (WHO)
Pharmacokinetic data
Elimination half-life	9 hours
Identifiers
CAS Number	511-12-6
PubChem CID	10531
DrugBank	APRD00476
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₃₃H₃₇N₅O₅
Molar mass	583.678 g/mol